The Uromigos

401 Episodes

1. Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜

   Published: 10/24/2024
2. Episode 362: 膀胱がんの最新の話題〜周術期薬物療法とADC〜

   Published: 10/24/2024
3. Episode 361: The Role of Monotherapy AR Inhibition in Prostate Cancer

   Published: 10/22/2024
4. Episode 360: The SUNRISE Program in Bladder Cancer

   Published: 10/15/2024
5. Episode 359: #UromigosLive24 - IO after IO in RCC

   Published: 10/9/2024
6. Episode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville

   Published: 9/30/2024
7. Episode 357: #UromigosLive24 - Peri-operative Therapy in Bladder Cancer

   Published: 9/30/2024
8. Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC

   Published: 9/28/2024
9. Episode 355: #UromigosLive24 - Radioligands in prostate cancer

   Published: 9/28/2024
10. Episode 354: #UromigosLive24 - T cell directed therapy in prostate cancer

    Published: 9/28/2024
11. Episode 353: #UromigosLive24 ADC session

    Published: 9/28/2024
12. Episode 352: ESMO 2024 - RCC and Bladder review

    Published: 9/23/2024
13. Episode 351: ESMO 2024 review part 1: prostate cancer

    Published: 9/21/2024
14. Episode 350: ESMO 2024 - NIAGARA

    Published: 9/16/2024
15. Episode 349: ESMO 2024 - Uromigos Japan!!

    Published: 9/16/2024
16. Episode 348: ESMO 2024 - UpFrontPSMA

    Published: 9/15/2024
17. Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer

    Published: 9/15/2024
18. Episode 346: ESMO 2024 - PEACE-3: Enza/Radium-223 vs Enza in mCRPC

    Published: 9/14/2024
19. Episode 345: ESMO 2024 - SUNNIFORECAST: Ipi/Nivo vs SOC in Non-clear Cell RCC

    Published: 9/14/2024
20. Episode 344: ESMO 2024 - NKT2152, a HIF inhibitor in RCC

    Published: 9/14/2024